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ABSTRACT 
 
 
Layered double hydroxides (LDHs), have been known for many decades as a catalyst and 
ceramic precursors, traps for anionic pollutants, and additives for polymers. Recently, their 
successful synthesis on the nanometer scale opened up a whole new field for their application 
in nanomedicine. Here we report the efficacy of Mg1-xAlx (NO3) x (OH)2 LDH nanoparticles 
as a carrier and for controlled release of one of the non-steroidal anti-inflammatory drugs 
(NSAID), sodium salicylate. Mg1-xAlx (NO3)x(OH)2.nH2O nanoparticles were synthesized 
using co-precipitation method from an aqueous solution of Mg(NO3)2.6H2O and 
Al(NO3)3.9H2O. Salicylate was intercalated in the interlayer space of Mg-Al LDH after 
suspending nanoparticles in 0.0025(M) HNO3 and 0.75 (M) NaNO3 solution and using anion 
exchange method under N2 atmosphere. The shift in the basal planes like (003) and (006) to 
lower 2θ value in the XRD plot of intercalated sample confirmed the increase in basal spacing 
in LDH, which is because of intercalation of salicylate into the interlayer space of LDH. 
FTIR spectroscopy of SA-LDH nano hybrid revealed a red shift in the frequency band of 
carboxylate group in salicylate indicating an electrostatic interaction between cationic LDH 
sheet and anionic drug. Differential thermal analysis of LDH-SA nanohybrid indicated higher 
thermal stability of salicylate in the intercalated form into LDH as compared to its free 
state.DLS studies showed a particle size distribution between 30-60 nm for pristine LDH 
whereas salicylate intercalated LDH exhibited a particle size distribution between 40-80 nm 
which is ideal for its efficacy as a superior carrier for drugs and biomolecules.The cumulative 
release kinetic of salicylate from MgAl-LDH–SA hybrids in phosphate buffer saline (PBS) at 
pH 7.4 showed a sustained release of salicylate up to 72 h. The drug release kinetic closely 
resembled first order release kinetics through a combination of drug diffusion and dissolution 
of LDH under physiological conditions.The hemocompatibility tests performed on the 
samples showed that Mg Al LDH was compatible with human blood. Cytotoxicity of LDH- 
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SA nanohybrid was determined using MTT assay, subsequently the DNA fragmentation test 
on human kidney cells. The results suggest that SA intercalated into LDH was much less 
cytotoxic than the bare SA on kidney cells. 
 
. 
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INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 
1.1 LAYERED DOUBLE HYDROXIDE:- 
 
 
 
Numerous efforts have been made in recent times to develop novel drug carrier for transport, 
storage, and release of the drug at the targeted sites in the human body. Such nanocarriers 
exhibit numerous advantages over conventional forms of dosage that include enhanced 
bioavailability, greater efficacy and safety, controlled and prolonged release time, and 
unpredictable therapeutic response [1]. So far, a large number of materials have been 
employed as various drug delivery systems, such as biodegradable polymers, hydroxyapatite, 
xerogels, hydrogels [1], guar gum nanoparticles [2], fluoride hollow structures[3], 
superparamagnetic nanoparticles [4,5], functionalized mesoporous materials [6–8] etc. 
Layered double hydroxides (LDHs) [9] being one of the most efficient drug carrier amongst 
these, are widely used. LDHs are considered to be the new generation materials, comprising a 
two-dimensional layered structure similar to that of mineral brucite, Mg(OH)2[10]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1: Schematic representation of Layered Double Hydroxide. 
 
 
Layered Double Hydroxides (LDHs) are a special type of ceramic with hydrotalcite-like clay 
material. They have surface layers formed of positively charged brucite layers made up of 
mixed metal hydroxides of divalent and trivalent metals, with exchangeable intercalated 
negatively charged species in between the two surface layers. This negative charge 
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compensates for the positive charge of the brucite layer as shown in figure 1. Chemical 
composition of LDH is expressed as M(II)1-x M(III)x (OH)2 (An-)x/n × y H2O, where M(II) is 
divalent metal cation, M(III) is trivalent metal cation. ‘A’ is an interlayer anionic species. 
And ‘n’ is the charge on the interlayer anion, ‘x’ and ‘y’ are fraction constants. The brucite 
type layer is of the structure with hydroxyl (OH) groups in hexagonal close packing, and each 
divalent metal cation was octahedrally coordinated to six OH -groups. These octahedra share 
edges to form the layers. Because all octahedrally coordinated cations occupied sites between 
oxygen layers, this structure is described as trioctahedral; each OH
-
 group surrounded by 
three occupied octahedral positions. LDH have many physical and chemical properties that 
are surprisingly similar to those of clay mineral. These properties are their layered structure, 
wide chemical compositions (due to the variable isomorphous substitution of metallic 
cations), variable layer charge density, ion-exchange properties, reactive interlayer space and 
rheological and colloidal properties. But because of their anion-exchange properties, LDHs 
are also known as “anionic clays.” The activated Mg Al-LDH film proved promising to be 
used as a precursor to synthesize monolithic catalyst for aldol condensation of acetone and 
other base-catalyzed reactions.[11] Structured LDHs were one new type of promising 
material due to their ability to capture organic and inorganic anions that could be used in 
water treatment. Layered double hydroxides (LDHs) had been known for many decades as 
catalyst and ceramic precursors, traps for anionic pollutants, catalysts and additives for 
polymers. But their successful synthesis on the nanometer scale a few years ago opened up a 
whole new field for their application in nanomedicine.LDHs are one of the ideal candidates 
for a wide range of agricultural applications. It is usually prepared under ordinary conditions 
of temperature, pressure, and so on, as a precipitate from solutions using environmentally 
benign methods. So it is easy to synthesize LDH with the desired anion(s) in the interlayer 
region for careful selection of the combination of metals and the organic compound. Among 
the many different nanoparticles that have been shown to facilitate gene and drug delivery, 
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LDH nanoparticles have attracted particular attention owing to their many desirable 
properties. Anionic drugs and functional biomolecules could easily be intercalated into the 
gallery space of LDH nanoparticles and also be released by deintercalation in the 
physiological system. Nanotechnology application to medicine has enabled the development 
of functionalized nanoparticles that, acts as carriers. They were loaded with drugs or genetic 
material that could be released with a controlled mechanism to specific sites of the organism 
[11]. Besides drug carrying capabilities, the functionalization of nanocarriers also facilitates 
their transport to primary target organs. Thus, bioavailability and efficiency of drug 
molecules is much more enhanced as being intercalated into the interlayer space of LDH as it 
can avoid enzymatic and environmental degradation during its circulation inside the body. 
Also, this category of nanocarrier is administrable via intravascular/pulmonary route and may 
be used for simultaneous targeted (chemo/gene) therapy and molecular imaging. Besides 
drug carrying capabilities, the functionalization of nanocarriers also facilitates their transport 
to primary target organs. 
 
1.2 LDH- DRUG NANOHYBRID:- 
 
 
LDH-drug nanohybrids have a positive zeta potential. Therefore, the nanohybrid particles can 
approach and adhere to the negatively charged cell membrane via electrostatic interaction. 
These nanohybrids can be internalized into the cell by phagocytosis (LDH agglomerates, 
particles larger than 500nm) and endocytosis (individual crystallite of smaller size, < 300nm). 
Endocytosis leads to quicker uptake of LDH nanoparticles. The cellular uptake can be 
enhanced by decreasing the particle size, adjusting the zeta potential and conjugating the 
ligands to enhance the receptor-mediated endocytosis process. Using LDH as drug delivery 
agent is advantageous. This is because of its easy preparation, particle size control, versatile 
composition, very good biocompatibility, pharmaceutical antacid behavior, very low 
cytotoxicity, controllable surface charge density, and easy attachment of targeting moiety. 
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Similar to intercalation process, de-intercalation can also occur by ion exchange method with 
the surrounding ions such as Cl
-
 and phosphates. A possible release pathway is the acidic 
dissolution of hydroxide layer due to the low pH in the intracellular environment. This is the 
only pathway for release of big anionic species. 
 
1.3 SUMMARY:- 
 
 
Anti-cancerous drug molecules such as methotrexate, 5-flurouracil and anti-inflammatory 
drug molecules such as ibuprofen are negatively charged. Hence, those can be intercalated 
into the LDH molecule for its delivery into targeted location in the human body. As many of 
the biomolecules were negatively charged, they can also be intercalated into LDH including 
specific gene and DNA. Powdered LDHs have been described to be one of the most 
important green carriers or hosts for genes and drugs due to their excellent biocompatibility, 
bioresorbability and nontoxicity or low toxicity. MgAl-LDH finds application as an important 
component of drugs, or as nanocarriers for delivery of drug and genes into cells [13,14] 
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CHAPTER 2: - 
 
 
 
 
 
LITERATURE REVIEW 
2.1 LAYERED DOUBLE HYDROXIDE AS A NANOCARRIER: 
 
 
Layered double hydroxides (LDHs) are well established as excellent anion exchange 
materials. The tremendous scope for fine tuning the intercalation and deintercalation kinetics 
of LDHs were originated because of its variable chemical composition, physical and 
structural properties. It employs different LDHs with differing charge densities and basicities. 
Because of the strong electrostatic interaction, multivalent anions within the interlayer space 
of LDH are particularly preferred. [1] 
 
Intercalation of LDH with a variety of anions of pharmaceutical interest, such as salicylate, 
citrate, glutamate, and aspartate, was shown by Trontoet al.[2] Two different synthesis 
methods, a direct one (co-precipitation) and an indirect one (anion exchange of dodecyl 
sulfate samples) were used by authors. Variety of other molecules of biological interest such 
as ascorbic acid [3], biocatalysts [4], porphyrin [5], nucleotides [6], vitamins [7], amino acids 
and peptides [8,9] have also been intercalated into layered double hydroxides. 
 
Intercalation of non-ionic pentoses (ribose and 2-deoxyribose) into the Mg-Al and Zn-Al 
layered double hydroxides at ambient temperature was shown by Aisawa et al.[10], using the 
calcination-rehydration reaction with precursors being calcined at 500
o
C. In another study 
intercalation of several amino acids into Mg-Al LDH was investigated by Hibino et al [11]. 
 
As a model for a drug delivery system intercalation of adenosine triphosphate (ATP) into 
Mg-Al LDH was studied by Tamura et al [12]. Being biocompatible systems [13], LDHs 
were used in pharmaceutical technologies[14,15] and medicine as drug supports or matrices. 
The drug release rate is governed by the pH once encapsulated. Several pharmaceutical 
applications as excipients, drug stabilizers, [16, 17] ingredients in sustained-release have 
been found using Mg-Al LDH. This hybrid was also used for the therapy of digestive 
disorders [18] and the preparation of aluminum magnesium salts of antipyretic, analgesic and 
anti-inflammatory drugs. 
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Khan et al. showed intercalation of a series of cardiovascular, anti-inflammatory and 
analgesic agents like diclofenac, gemfibrozil, ibuprofen, naproxen, 2-propylpentanoic acid, 4-
biphenylacetic acid and tolfenamic acid into Li-Al-layered double hydroxide [19]. This drug-
inorganic hybrid material acts as a novel tunable drug delivery system. Ambrosial al.[20] 
found that all chloride ions of hydrotalcite-like compounds exchanged by ibuprofen anions, 
which produced an intercalation compound with a drug loading of 50% w/w. 
 
LDHs also acts as matrices for intercalation of non-steroidal anti-inflammatory drugs like 
Diclofenac [21]. Gordijo et al reported the immobilization of ibuprofen and copper-ibuprofen 
drugs on layered double hydroxides [22] Ion exchange, reconstruction, and coprecipitation 
reactions were used for the intercalation of ibuprofen into the LDH matrix. Immobilization of 
the drug and the copper-ibuprofen were performed by adsorption on the external LDH 
surfaces. 
 
In vivo pharmacological study on the interaction between hydrotalcite and indomethacin was 
carried out by Del Arco et al [23]. They showed that intercalation of the drug simultaneously 
reduced the ulcerating damage of the drug. The intercalated compounds thus obtained with all 
anti-inflammatory drugs were hybrid systems, which, at room temperature, exhibited fluid 
and solid state properties. Hydrotalcite quickly dissolves in acidic pH thus releasing the drug 
in molecular form. Synthesis and characterization of nanoscale magnetic drug-inorganic 
composites by direct co-precipitation was carried out by Sun et al [24] and Zhang et al.[25]. 
They also reported captopril (Cpl) and 5-aminosalicylic acid (5-ASA) intercalation in Zn-Al 
LDH coated on MgFe2O4 magnetic core particles. 
 
The design and synthesis of c-myc antisense oligonucleotide (As-myc)-LDH hybrid by simple 
ion exchange method was performed by Kwak et al [26]. As-myc has a detectable function in 
cells, it represents a useful model system that helps to study the role of proto-oncogenes in 
cellular proliferation and differentiation. The negative charge on As-myc molecule allows 
easy intercalation into LDH by ion exchange that thermodynamically forms stable structure 
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due to enhanced electrostatic interaction. The transfer of As-myc into HL-60 cells through 
endocytosis, enhanced due to the charge neutralization. However, in the cells the other anions 
present in the cytosol would partially replace the interlayer oligonucleotides. The antisense 
oligonucleotide molecules was intercalated in the LDHs enter cells through endocytosis or 
phagocytosis process. 
 
Leroux et al. reported the formation of Mg-Ga LDH-DNA nanohybrid using co-precipitation 
method. [27]. A parallel orientation of the DNA double helices in the interlamellar spaceways 
was indicated by the X-ray diffraction analysis. Inhibition of the crystal growth occurred due 
to the presence of adsorbed DNA macromolecules. The homogeneous populations of 
particles revealed that mean hydrodynamic diameters of macromolecules ranging from 90 to 
150 nm, were compatible with cell penetration through endocytosis. 
 
A novel method developed by Tyner et al [28], helped to deliver poorly water soluble drugs 
by intercalation into an LDH host. An alkaloid named camptothecin derived from the 
Chinese tree camptotheca acuminate. This alkaloid and its derivatives have unique ability to 
inhibit DNA topoisomerase, which traps the enzyme, thus inhibiting DNA replication and 
consequently killing the cancer cells. Successful intercalation of methotrexate (MTX), 5-
fluoouracil (5-Fu) and folinic acid (FA) into the interlayer space of Mg-Al-LDH was shown 
by Choy et al. [29-31]. Intercalation of these molecules into the hydroxide interlayer space 
was indicated by x-ray diffraction patterns and spectroscopic analyses, were found to be 
stabilized in the tilted longitudinal monolayer mode (46
o
 for MTX and 50
o
 for folinic acid) 
by electrostatic interaction. A drug–LDH system composed of MgAl–LDH and folate 
derivatives such as folinic acid and methotrexate (MTX) were designed in the study of 
Gilman AG et al. [32]. They showed that folinic acid finds application in therapy for different 
forms of cancers, prevention, and treatment of vitamin deficiencies [33]. The intercalation 
reaction took place without any deterioration of either LDH or drugs. Tumor cell suppression 
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was more efficient if MTX–LDH hybrid was used. So LDH could be used as an excellent 
inorganic carrier for an advanced biocompatible drug delivery system. 
 
Qin et al. studied intercalation of folic acid using in-situ co-precipitation and anion exchange 
methods into Mg-Al-LDH.[34]. The stability of folic acid molecules between the hydroxide 
layers in LDH particles was demonstrated by XRD and also showed that it remained intact. 
The hybrid was constructed by both co-precipitation and ion exchange methods, with an 
interlayer spacing of 15.3 and 16.0 Å, respectively. UV-VIS method was used to calculate the 
drug loading in the hybrid system. It showed that nanohybrid prepared using co-precipitation 
route acquired heavier (19.32%) folic acid loading. 
 
A biocompatible charge neutral Mg-Al LDH system had been built up by Wang et al. [35], 
through a calcination-restructure method, for the vehiculization of 5-FU. The interlayer 
arrangement of 5-FU depends on various patterns of aging treatment and different swelling 
solvents. The release studies showed a rapid 5-FU release from LDH during the first 40 min 
(≈ 65 % at pH4, and ≈ 50 % at pH 7) that was followed by a slightly sustained one. The total 
amount of anti-cancerous drug released from the hybrid material was ≈ 85 % at pH 4 and ≈ 
75 % at pH 7, after ≈ 2.5 hours. The different release mechanisms attributed to the 
differences in the release patterns between both pHs. At pH 7, the drug release mechanism 
was thought to be based on an ion-exchange process between 5-FU anions pillared in the 
lamella host and phosphate anions of the buffer solution. On the contrary, at pH 4 the LDH 
could start a dissolution process so that the faster 5-FU release occurred through ion-
exchange and the removal of the inorganic host [36]. 
 
Manjusha Chakraborty, et al. [37] successfully synthesized Layered double hydroxide (LDH) 
 
– methotrexate (MTX) nanohybrid using ex-situ and in-situ processes. They showed that 
depending on the two synthesis routes used to synthesize LDH–MTX nanohybrid, its particle 
size as well as morphology could be varied at the nanoscale. LDH–MTX nanohybrid 
synthesized using in situ process exhibited lower aspect ratio as compared to ex-situ 
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synthesized LDH–MTX nanopowder. Nearly four times drug loading was exhibited by the 
ex-situ hydrothermal sample in comparison to the other two samples. The release behavior 
also corroborated the above observation and showed a controlled release profile of the drug 
delivery formulations. In their another paper [38], successful intercalation of MTX in the 
interlayer space of Zn-Al LDH was confirmed and suggested enhanced stability of MTX in 
the nano hybrid cationic framework. 
 
Rossi et al. showed intercalation of ferulic acid into a hydrotalcite like LDH by a simple ion 
exchange process. [39]. The sunscreen properties of ferulic acid were potentially improved 
and protected from degradation and irradiation because of LDH. Thus, the intercalated 
compound could be formulated into a potentially useful silicone-based cream for sunscreen 
formulation. A new protection model designed by Perioli et al [40], where studies on the 
intercalation products of PABA into lamellar structures of Mg-Al and Zn-Al layered double 
hydroxides were reported. Feng et al. observed the interaction between the organic anion of 
2-hydroxy-4-methoxy-benzophenone-5-sulfonic acid (HMBA) and Zn-Al-LDHs. [41]. 
HMBA-LDH intercalation system exhibited an enhanced photo- and thermal stability, it did 
not affect the UV absorption capacity. 
 
Layered double hydroxides (LDH) have extensive applications as catalysts, catalyst 
precursors support, adsorbents, optical and electric functional materials, flame retardants and 
polymer stabilizers. Thus owing to the rich intercalation chemistry, LDH-based controlled 
release systems have recently gained particular attention. LDH powders and films widely 
explored as catalysts and adsorbed materials. The resulting activated structures obtained by 
calcination and rehydration, exhibit enhanced performances. Powdery LDHs are typically 
used as additives in flame retardants and concrete, and as a nanocarrier for drugs, gene 
molecules, biomedical products, and functional molecules. Ye Kuang et, al [42] discussed the 
preparation of novel LDH micro/nanostructures. They also developed the novel applications 
of these LDHs in many fields such as separation, catalyst, drug and gene delivery, and 
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electrode modifier for energy harvesting devices. Furthermore, the relationship between the 
novel structures and the enhanced properties of LDH micro/nanostructures, as well as 
understanding the specific structures prepared from confined nucleation and growth need to 
be explored. Our knowledge of controlled LDH nanostructures, resultant properties and 
applications would advance from these aspects. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2: Role of Layered Double Hydroxides as a functional material 
 
 
 
 
Hwang et al. reported the intercalation of vitamins A, E, and C into LDHs and zinc basic salts 
by coprecipitation method. [43, 44]. The hybrid was coated with a porous shell of silica to 
enhance the stability of intercalated vitamins and dispersion property of the hybrid 
nanoparticles. Bin Hussein et al. [45] reported dealing with LDHs for cosmetic applications 
and intercalated naphthol blue black into Mg Al–LDH, which made its formulation more easy 
and broad. 
 
LDHs are one of the ideal candidates for a wide range of agricultural applications. Their 
framework could be decomposed into plant nutrients. Whereas their structure offered 
interesting features such as accommodation and controlled release of various active anionic 
agro-substances, high buffering capacity, high water retention ability, and acid neutralizing 
potential. Development of LDHs for agricultural purposes was not high and urgent, since 
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clays are naturally abundant and inexpensive, which is the important reasons for the retarded 
development of LDHs in agriculture. As serious contamination of soils and water arises from 
various anionic compounds, and development of the acidic property was found in cultivated 
soils, attempts of removal of anionic ions and pesticides by adsorption to LDHs have gained 
attention. Studies to develop the potential of LDHs as plant nutrients, pesticides, growth 
regulators, and active principle in animal feeds were carried out by Olanrewaju et al.[46]; 
Lakraimi et al. [47]. 
 
Synthesis of nitrate-LDH at ambient condition without any considerable contamination 
by carbonate was performed by Olanrewaju et al. [46], and found such LDHs as a potential 
slow-release fertilizer. Intercalation of plant growth regulator, α-naphthalene acetate through 
coprecipitation was investigated by Bin Hussein et al. [45] to explore the protected storage 
and controlled release in natural environments. Pesticide formulations that mainly consisted 
of various organic solvents were given more attention. Intercalation of 2,4-dichlorophenoxy 
acetate, a broad leaf herbicide into ZnAl–LDH by ion exchange reaction was reported by 
Lakraimi et al. Therefore, the application of LDHs in agriculture could be more extensively 
expanded in near future as their acid neutralizing potential, and high anion adsorption 
capacity. 
 
The sorption experiments carried out by Lucelena Patricio Cardoso et.al.[48] at different 
concentrations to obtain the isotherms, revealed that increasing anion concentration leads to 
the preferential intercalation of organic anions, which are arranged a bilayer in a position 
vertical to the LDH layers. The pH value of the organic anion solution did not exert any 
effect on the removal of these anions from the solution. All sorption isotherms had a very 
similar profile, and the number of removed anions at both pH values were close. 
 
Reversible intercalation of phenoxy methyl penicillin into a layered double hydroxide was 
reported by Li et al. (2006) [49], and they showed that the resulting system exhibited 
effective anti-bacterial activity. In the pharmaceutical industry, LDHs are being used as 
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excipients and active principles. LDHs thus acting as laminar solids were revealed to be good 
excipients for anti-inflammatory drugs in formulations of controlled release as well as in 
solar protectors as reported by C Del Hoyo [50] et al. He also emphasized the importance in 
the synthesis of biosensors. LDHs can thus be considered as a group of promising materials 
in the development of new health applications. 
 
Despite several fundamental studies on the mechanism by which LDH nanoparticles deliver 
their payload, only limited success has been found on efficient delivery of large biomolecules 
so far as reported by Katharina Ladewig et.al [51]. Most of the reports focus on intercalation 
and delivery of molecular drugs (anti-inflammatory drugs, anticancer drugs, etc.) and small 
nucleic acids (PCR fragments, antisense oligonucleotides, siRNA, etc.), which are quite 
promising for future bio-applications. Challenges remain involving dedication to the problem 
of well-dispersed LDH nanoplatelets to realize non-toxic, biocompatible and biodegradable 
LDH carries into practical applications for drug and gene delivery. Since targeting of 
drug/gene-carrying LDH materials is difficult because of the ionic nature of their surfaces, 
Oh et al. [52] and Xu et al. [53] presented two ways to circumvent the targeting problem. 
First approach was by functionalization of LDH nanoparticles through condensation of APS 
on LDH nanoparticle surface. Secondly by varying the morphology of the particles so that 
they target different intracellular compartments. Ion exchange using nitrate as the interlayer 
anion and co-precipitation after adding Mg
2+
 and Al
3+
 ions into a sodium salicylate solution 
were the two intercalation methods that were studied in this case. 
 
 
 
2.2 STATEMENT OF THE PROBLEM:- 
 
 
Mg-Al-LDHs are widely used as a nanocarrier for delivery of non-steroidal anti-
inflammatory drug in a controlled and sustained manner. Though the problem lies in the 
synthesis and processing of uniformly dispersed drug intercalated stable LDH suspension, in 
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the nano range of 50-100 nm, to maximize its bioavailability and retention capacity inside the 
cellular compartment. 
 
Also, since these NSAIDs are very active in damaging kidney cells, the intercalation of 
NSAIDs into LDH may restrict the damaging capacity of NSAIDs to kidney cells, which has 
rarely being investigated. Here our objective is to study and optimize the synthesis parameter 
for obtaining uniform dispersed stable Mg-Al –LDH salicylate nanohybrid with an optimum 
size range in nanometre scale. We further investigate the effect of LDH-SA nanohybrid in 
restricting the damage of kidney cell while delivering the NSAID, through MTT Assay & 
DNA fragmentation test. 
 
A detailed study on synthesis and characterization of Mg-Al-LDH-SA nanohybrid has been 
carried out for further understanding the controlled and sustained release behavior of SA, 
under physiological conditions. 
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CHAPTER 3:- 
 
 
 
 
 
MOTIVATION & OBJECTIVE 
 
OF WORK 
3.1 MOTIVATION OF WORK:- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3: Schematic representation for different LDH applications 
 
 
 
The factors behind the motivation for using LDH as a nanocarrier for drug delivery are 
discussed below: 
 BIOCOMPATIBILITY: 

The term refers to the ability of the material to perform with an appropriate host 
response in a specific situation. The ambiguity of the term reflects the ongoing 
development of insights into how the biomaterials interact with the human body and 
eventually how those interactions determine the clinical success of a medical device. 
In this context, Mg Al LDH is highly biocompatible. 

 BIORESORBABLE : 
The term refers to those the materials that can be broken down by the body. 


That do not require any mechanical removals, such as sutures or the chlorhexidine 
chip. Mg al LDH nanoparticles are highly bioresorbable under physiological 
condition. 

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 CONTROLLED RELEASE: 

The term refers to the presentation or delivery of compounds in response to stimuli or 
time. This could be for purposes in several areas including agriculture, cosmetics and 
personal care, pharmaceuticals, and food science. Most commonly here it refers to the 
time dependent release in oral dose formulations. Drugs in intercalated form inside 
the Mg AL LDH shows controlled and sustained release behaviour under 
physiological condition. 

 HYDROPHILIC: 

It refers to materials having an affinity for water; readily absorbing or dissolving in or 
be wetted by water. Hydrophilic molecules typically have polar groups enabling them 
to absorb readily or dissolve in water as well as in other polar solvents. Because of 
hydrophobicity, Mg Al LDH can easily escape the reticuloendothelial system (RES) 
of human body and avoid phagocytosis by macrophages. 

 EASY SURFACE FUNCTIONALIZATION: 

It introduces chemical functional groups to a surface. This way, materials with 
functional groups on their surfaces can be designed from substrates with standard 
bulk material properties. Prominent examples were found in the biomaterial research. 
Mg Al LDH can be easily surface functionalized for attributing multifunctional 
properties to it. 

 EASY ENDOCYTOSIS: 

The process by which a living cell takes up molecules bound to its surface. It involves 
cellular ingestion by which the plasma membrane folds inward to bring substances 
into the cell. Being positively charged Mg-Al LDH can easily be attracted into 
negatively charged interior compartment of cells through endocytosis. 

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 3.2 OBJECTIVE OF WORK: 
 
 
 Synthesis of LDH with positively charged layers having two kinds of metallic cations - 
divalent, e.g., Mg and trivalent, e.g., Al, of a general formula [M
2+
1–xM
3+
x(OH)2]
x+
(A
n
 

 
)
x/n·mH2O, (x is equal to the molar ratio of M
2+
/(M
2+
 + M
3+
) and A
n–
 is an anion)  by co- 
 
precipitation under nitrogen atmosphere.  
 Incorporation of anionic anti -inflammatory drug by anion exchange route. 

 Characterization of LDH- drug nanohydrid using XRD, FTIR, dynamic light scattering 
technique, transmission electron microscopy. 

 Estimation of drug loading using C, H, N or thermogravimetric (TGA) Analysis. 

 Study on the drug release behavior of the LDH- drug nanohybrid under physiological pH 
in vitro. 

 Study on cytotoxicity of Mg-Al LDH –SA nanohybrid on human embryonic kidney cells. 
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CHAPTER 4:- 
 
 
 
 
EXPERIMENTAL WORK: 
4.  EXPERIMENTAL PROCEDURE: - 
 
 
4.1 MATERIAL:- 
 
 
Magnesium nitrate hexahydrate [ Mg (NO3)2.6H2O], aluminum nitrate nonahydrate [Al 
(NO3)2.9H2O], ammonium hydroxide [NH 4 OH] were purchased from Sigma-Aldrich, USA. 
Sodium salicylate [NaOSal] was synthesized from salicylic acid [HOSal] (Merck, India) and 
sodium hydroxide [NaOH] (Merck, India). Deionized and decarbonated ultra-pure water 
(Millipore, specific resistivity18 MΩ) was used in all preparations and the chemicals utilized 
in this study were used as received without further purification. 
 
 
 
4.2 METHOD:- 
 
 
4.2. 1 SYNTHES IS OF Mg -Al LDH nanoparticle : - 
 
 
0.495 (M) Mg (NO3)2.6H2O (19.1262 g) and 0.165 (M) Al (NO3)2.9H2O (9.321 g) were 
dissolved in 150 ml of water to synthesize Mg-Al LDH with Mg: AL in ratio of 3:1. To 
maintain the pH of the mixed precursor solution at pH 10, ammonia was used, along with 
magnetic stirring. The stirring was continued for further 24 hours. The appearance of a white 
gelatinous precipitate indicated the formation of Mg-Al-LDH. The precipitate was collected 
by centrifugation and repeatedly washed by redispersing it in water followed by 
centrifugation (at 3000 rpm for 5mins) to remove excess nitrate anions. The washed LDH 
precipitate was then vacuum dried for 24 hrs to get Mg AL-LDH nanopowder. With a target 
amount of 3 grams of pristine LDH to be produced,5 grams of Mg(NO3)2.6H2O and 0.6 
grams of Al(NO3)2.9 H2O were taken . After the product obtained it was measured and found 
that amount of pristine LDH produced was 2 grams , which was calculated to be around 68 % 
of the theoretical yield. 
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Preparation of Mg Al Layered Double Hydroxide Nanoparticle: 
 
 
 
 
 
A solution of mixed metal salts of Mg (NO3 ) 2and Al(NO3)3 in 3:1 ratio in water 
was vigorously stirred. 
 
 
 
 
Along with stirring Ammonia was added to induce co-precipitation. 
 
 
 
 
 
 
Material was synthesized at pH 10. 
 
 
 
 
 
Precipitate was kept in stirring at room temp for 24 hrs. 
 
 
 
 
 
 
Sample was centrifuged, washed and then vacuum dried for 24 hrs. 
 
 
 
 
 
4.2.2 Synthesis of Sodium Salicylate from Salicylic Acid:-
HOSal + NaOH -------- NaOSal + H2O. 
 
One mole of Salicylic Acid reacts with one mole of Sodium Hydroxide in an aqueous 
medium to form a mole of sodium salicylate and a mole of water. The molar mass of NaOH 
is approximately 0.290 times that of salicylic acid (SA); thus 10 grams of SA would be 
reacted with 2.90 grams of NaOH.. It is important to use 1:1 molar ratio so that there would 
 
be no excess NaOH or SA in the final product. NaOH was dissolved in as little distilled water 
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as required to solubilize, whereas SA was dissolved in another beaker in a little amount of 
ethanol as required to solubilize it completely. The two solutions were mixed, subsequently 
heated at a temperature of 65 to 80
o
 C and vigorously stirred on a stirrer until the solution 
thickened and became pale yellow. Finally, the crystals precipitated out and eventually 
became completely dry and thus Sodium Salicylate was obtained. 
 
4.2.3.1 Synthesis of Mg Al -Salicylate LDH hybrid nanoparticle using co - precipitation 
method : -  
 
Intercalation of sodium salicylate into it s interlayer space was also performed using the co - 
precipitation method . 0 .495 (M) Mg (NO3)2.6H2O (19.1262 g) and 0.165 (M) Al 
(NO3)2.9H2O (9.321 g) with Mg: Al in ratio of 3:1, were dissolved in 150 ml of water 
folloewed by addition of 1 gm of sodium salicylate under nitrogen atmosphere with constant 
atirring. To maintain the pH of the mixed precursor solution at pH 10, ammonia was used, 
along with magnetic stirring. The stirring was continued for further 24 hours in nitrogen 
atmosphere The appearance of a white gelatinous precipitate indicated the formation of Mg-
Al-LDH- SA hybrids. The sample was then centrifuged , washed with distilled water thrice t 
o remove nitrate and excess salicylate and then vacuum dried.  
 
4.2.3.2 Synthesis of Mg Al -Salicylate LDH hybrid nanoparticle using anion exchange 
method : -  
 
Subsequentl y after the preparation of the Mg - Al LDH particle and s odium Salicylate, it 
was now time for the intercalation of the sodium salicylate drug into the pristine LDH to 
obtain the Mg- Al LDH - salicylate nanohybrid. Two gm of salicylate was dissolved in 50 ml 
water of pH 7.5 (pH was raised by the addition of 25% NH4OH) and the solution was added 
to100 ml aqueous suspension in 0.0025(M) HNO3  
 
and 0.75 (M) NaNO3 containing 1 g of LDH. The pH of the LDH- Salicylate mixture was 
raised to 8.5 by dropwise addition of 0.01 M NaOH. The action mixture was agitated for 72 
 
 
 
24 
hours in a nitrogen atmosphere. The product, MgAl-LDH– Salicylate, was centrifuged, 
washed with deionized water and then dried in a vacuum oven at 50 
o
C. 
 
 
 
 
 
 
 
Pristine LDH (1 gm) was suspended in 0.0025 (M) HNO3 and 0.75 (M) NaNO3solution 
to maintain the pH of the sample at 6 
 
 
 
 
Stirring of this sample was done for 24 hours .Then the sample was centrifuged (8000 rpm 
for 5 mins). 
 
 
 
 
Then resuspended in 2 gms of sodium salicylate solution in controlled N2atmosphere 
& stirring was done again for 24 hours. 
 
 
 
 
 
Sample was washed thoroughly by centrifugation(8000 rpm for 5 mins). 
 
 
 
 
 
Then the sample wasvacuumdried at 50
o
 C. 
 
 
 
 
 
 
4.2.4 Preparation of PBS buffer solution:- 
 
An Erlenmeyer flask filled with 800 ml of dd H2O was kept on a magnetic stirrer maintaining 
its speed uniformly.0.8 g of NaCl, 0.2 g KCl, 1.44 g of Na2HPO4 and 0.25 g of KH2PO4 were 
added to the flask, and the solutes were allowed to dissolve for 3 to 5 minutes along with 
stirring. Before adjusting the pH of the solution, it was necessary to be ensured that there 
were no remaining undissolved salts in the solution. After stirring vigorously for 5 minutes, 
the speed of the stirrer was then slowed down. 1 M HCl was added dropwise to the solution 
using a pipette and mixed thoroughly in the solution. The pH of the 
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solution was measured with a calibrated pH meter. The pH of the solution was thus 
maintained at 7.4 
 
 
 
4.2.5 Preparation of samples for UV- Spectrophotometer Analysis:- 
 
20 mg of MgAl LDH–Salicylate formulation was dispersed in 2 mL of PBS of pH 7.4 in 8 
different eppendorfs, marked and kept at a constant stirring. After a definite time interval, one 
Eppendorf was taken at a time and centrifuged (at 3000 rpm for 5mins). The solvent was then 
collected in a tube, filtered through 0.2 μm filter paper and the filtrate was kept for analysis, 
using a UV-visible spectrophotometer. 
 
 
 
4.3 Characterization of synthesized powders 
 
 
4.3.1 X-Ray Diffraction Method:- 
 
X-ray diffraction relies on the dual wave/particle nature of X-rays to obtain information about 
the structure of crystalline materials. A primary use of the technique is the identification and 
characterization of compounds based on their diffraction pattern. Bragg's Law described the 
diffraction of X-rays by crystal, [nλ= 2d sin θ, where λ = wavelength of x-ray, n = order of 
diffraction.]. The directions of possible diffractions depend on the size and shape of the unit 
cell of the material.Powder X-ray diffraction (XRD) patterns for MgAl LDH and MgAl LDH 
 
–Salicylate powders obtained with X’Pert High Score diffractometer (Rigaku, Japan) using 
CuKα ( λ- 1.5418˚ A) radiation at 40 mA, 40 kV. A step size of 0.005˚ was used in the scan 
range 1-80˚ (2θ). The instrument model used here is X-Pert, PANalytical, PW 3040/00, 
Netherlands. 
 
4.3.2 Zetasizer –Particle Size Analysis:- 
 
The particle size analyzer measures the size of the particle in a sample. It measures particle 
size in the size range of 1nm- 3µm.Dynamic light scattering at 90 degrees is used to measure 
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the particle size of the sample. It thus helps in the particle size determination of nanoparticles, 
surfactants, micelles, and colloids. The instrument model used here is MicrotracZetatrac, PA 
(USA). 
 
4.3.3 Transmission Electron Microscopy (TEM) 
 
In this Transmission Electron microscope, an electron beam from an electron gun is 
transmitted through an ultra-thin section of the microscopic object and the image is magnified 
by the electromagnetic fields. It is used to observe finer details of internal structures of 
microscopic objects like bacteria and other cells. Particle size and morphology of LDH and 
LDH-SA nanohybrid powders were examined using a transmission electron microscope 
(TEM) (Tecnai G
2
 30ST FEI, Netherland) operated at an acceleration voltage of 120 KV. 
 
4.3.4 Fourier Transfrom Infra Red Spectroscopy (FTIR) 
 
 
FT-IR stands for Fourier Transform Infrared, the preferred method of infrared spectroscopy. 
FTIR was used to characterize the chemical functional groups present in materials, based on 
the characteristics of vibrational and rotational energies of different molecular bonds. Fourier 
transform infrared (FTIR) spectra of the prepared powders were recorded at room 
temperature. KBr (Brooker,≥ 99%) pellet method (sample: KBr = 1:100) on a F Varian 3600 
 
(USA) spectrometer in the 400–4000 cm-1 range with an average of 10 scans were used.The 
instrument model used here is Perkin Elmer, USA/ RX-I FTIR. 
 
4.3.5 Differential Scanning Calorimetry (DSC) and Thermogravimetry (TG) 
 
Analysis 
 
The Differential Scanning Calorimetry (DSC) is a thermoanalytical technique in which the 
difference in the amount of heat required to increase the temperature of a sample relative to a 
reference material measured as a function of temperature. The working temperature can reach 
up to 1500
o
C in a controlled atmosphere. On the other hand, thermogravimetry (TG) 
determines the change in weight in relation to temperature. The DSC-TG instrument helps in  
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the determination of phase transition temperature, the heat of crystallization, weight loss in 
materials on heating, specific heat measurement, and study of reaction kinetics. The 
thermogravimetric (TG), and differential scanning calorimetry (DSC), of LDH and LDH-SA 
nanopowders were studied on 50 mg of powder samples using a TG/DSC analyser (Netzsch, 
Germany, STA449C/4/MFC/G.). The measurements were recorded from 50˚C to 1000˚C at 
10˚C/min heating rate in air. 
 
 
4.3.6 Field Emission Scanning Electron Microscopy (FESEM) 
 
The FESEM stands for Field Emission Scanning Electron Microscope and facilitates ultra-
high resolution microstructural characterization and analysis of ceramic and metallic samples. 
It combines advanced optics (including a two-mode final lens), SE/BSE (Secondary 
Electrons /Back-scattered Electrons) in-lens detection and beam declaration. Since being 
equipped with EDAX, it helps in composition mapping and elemental analysis. SEM images 
of the prepared sample were recorded with beam landing energy down to 50 V, and with a 
resolution of 1.4 nm @ 1 kV without beam deceleration. The instrument model used for the 
experiment is Nova Nano SEM/ FEI. 
 
4.3.7 CHN Analyzer:- 
 
A CHN analyzer helps us to analyze the Carbon, Hydrogen, Nitrogen, Oxygen content of an 
unknown organic compound. This helps in identification of the product in terms of its 
molecular formula. The compound of interest combusted in a furnace at a high temperature 
under oxygen stream. During the combustion process mostly the oxides of the concerned 
elements were formed in the form of gases. They are then separated and directed to a detector 
consisting of inert gases like helium or argon as a carrier for quantitative analysis.Thus, 
measurement of carbon, hydrogen, and nitrogen contents of the sample are obtained with fair 
accuracy. The instrument model used here is Elemental Analysen Systeme, Germany / Vario 
EL. 
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 4.3.8 Atomic Absorption Spectroscopy:- 
 
Atomic Absorption Spectroscopy determines the presence of metal in liquid samples in as 
low as ppm level. Metals absorb ultraviolet light in their elemental form when excited by 
heat. This instrument searches for a particular metal by focusing a beam of UV light at a 
specific wavelength range (190-900 nm) through a flame into a detector. The sample of 
interest was aspirated into the flame. The instrument then measures the intensity converting it 
into absorbance value. Samples tested and measured against calibrated curves constructed by 
running standards of various concentrations. Here 0.02 mg of Mg- Al LDH nanopowder was 
taken per ml of PBS buffer solution in small eppendorfs. The eppendorfs are marked and kept 
at constant stirring. Readings were taken after picking up of one eppendorf at a time, 
centrifuging it at 3000 rpm for 5 minutes, and then gently the solvent is collected in another 
eppendorf. The same procedure was followed with all the other test eppendorfs. The 
instrument model used here is AAS Shimadzu 24, Japan. 
 
4.3.9 UV-Visible Spectrometer:- 
 
 
 
The process of identification and quantification of chemical species by measuring the 
absorption of monochromatic electromagnetic radiation having a wavelength in the UV-VIS 
range ( 200-900 nm) is referred to as UV- Visible spectroscopy. Routinely being used in 
analytical chemistry, for the quantitative determination of different analytes, such as 
transition metal ions, biological macromolecules, and highly conjugated organic compounds. 
The instrument model used here is Lambda 35, Perkin Elmer, USA. 
 
20 mg of MgAlLDH–Salicylate formulation was dispersed in 2 mL of PBS of pH 7.4 in 8 
different eppendorfs, marked and kept at a constant stirring. After definite time interval, one 
eppendorf was taken at a time and centrifuged (at 3000 rpm for 5 mins). The solution was 
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then collected in a tube, filtered through 0.2 m filter paper and the filtrate was kept for 
 
analysis using a UV-visible spectrophotometer. 
 
 
 
 
4.3.10 HEMOCOMPATIBILITY Analysis:- 
 
 
 
Hemocompatibility tests were done for the samples as per the American Society for Testing 
and Materials (ASTM) standard protocol. It figures out the extent of hemolysis, i.e.the 
rupture or destruction of red blood cells, in the presence of the three samples. Here for the 
tests to perform fresh goat blood was collected in the presence of TriSodiumCitrate (TSC). 
The hemocompatibility test were performed on 3 different samples, suah as pristine Mg-Al – 
LDH (Mg: Al=2:1), Mg-Al –LDH intercalated with salicylic acid, and pure salicylic acid 
(SA). 0.05 g of each of these samples were taken in the tubes followed by the addition of 9.5 
ml of saline in each of the tubes. For positive control, 0.5 ml of diluted blood was mixed with 
0.1 N HCl and subsequently diluted to 10 ml. As HCl has the ability to rupture the Red Blood 
Cells it can act as a positive control. For the negative control 0.5 ml of blood was diluted to 
10 ml with the Saline solution. The centrifuge tubes were then incubated at 37
o
C for 60 
minutes (1 hour) in Oswald BOD incubator (IRIC-10). After being incubated, they were 
centrifuged at 4000 rpm for 10 minutes. Finally, the Optical Density (OD) of all the samples 
were measured at 545 nm using a UV-visible Spectrophotometer.The percentage (%) 
hemolysis was calculated as per the following formula:- 
 
 
 
 
 
 
 
 
 
 
If the % hemolysis is <5 then the material is considered as highly hemocompatible, a value 
<10 indicates hemocompatible whereas a value > 20 indicates non-hemocompatible. 
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 4.3.11MTT ASSAY Analysis:- 
 
The term MTT assay refers to a colorimetric assay used for assessing cell metabolic activity. 
This assay was performed to measure the cell viability, assessed through, ‘color-change’ 
phenomenon from yellow colored tetrazolium salt, MTT {3-(4,5-diamethyl thiazol-2-yl)-2,5-
diphenyltetrazolium bromide} to purple colored formazan. These cell viability and 
cytotoxicity assays used for drug screening and cytotoxicity tests of chemicals were 
performed on HEK293 cells commonly known as the Human Embryonic kidney cells. The 
HEK 293 cells were taken, and their culturing was done in an MEM (Minimum Essential 
Media) mixed with 10 % FBS (Foetal Bovine Serum) media. This mixture provides the 
complete nutrition for the cells to flourish. Stored cells were thus retrieved and seeded in 96 
well plates containing the media and kept for growth in a CO2 incubator (Heracell 150i, 
Thermospecific). A controlled atmosphere of 37°C and 5 % CO2 was maintained. To obtain a 
dose response effect of the drug, the drug of interest was diluted to 5 different concentration. 
In the growth media in parallel, the cells were thus treated with the controlled media to assess 
its effect on cells. Cells were treated with three samples such as pristine LDH, LDH-SA and 
free SA at various concentration and the cells were incubated upto 48 hours at 37°C. The 
samples without any LDH or SA addition was treated as positive control. To detect the cell 
viability , the MTT working solution was prepared by diluting the stock solution (stock 5 mg 
/mlPBS, pH-7.2) in growth media without FBS to the final concentration of 0.8 mg/ml. 100 
µl of MTT working solution was added to each well and again incubated for 4 hours in a CO2 
incubator. After incubation, the media was carefully removed without disturbing the 
formazan precipitate and dissolved in 100 µl of 100 % DMSO. Hence again incubated in the 
dark for 15 minutes and the colorimetric estimation was performed on a microplate reader at 
570 nm. 
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4.3.12 DNA FRAGMENTATION Analysis:- 
 
This test clearly indicates the effect of the ceramic Mg-Al LDH nanomaterial, bare salicylic 
drug and the Mg-Al LDH-SA nanohybrid on the HEK 293 cells. The protocol used for this 
experiment provided a qualitative method for assessing cell death by detecting the DNA 
fragments using agarose gel electrophoresis. One of the classic features of cell death is the 
cleavage of the genomic DNA into oligonucleosomal fragments represented by multiples of 
180 – 200 base pairs. Characterization of this event could be aided by visualizing these 
fragments. The reagents used for this experiment were the agarose gel, Ethidium Bromide, 
TAE [Tris base, Acetic acid, EDTA], TES lysis buffer. 
 
The cells were taken and centrifuged at 2000 rpm in an Eppendorf using a table top 
centrifuge for 5 mins at 4°C, and the supernatants were removed. 20µl of TES lysis buffer 
added and the cell pellets were mixed with it. After the addition of 10 µl of RNase cocktail, 
the cells were incubated for 120 minutes at 37° C. Consecutively 10µl of Proteinase K was 
added, and the cells were incubated at 50°C for overnight. The cells are then taken out of 
incubation and loaded into dry wells of a 1-1.5 % agarose gel in TAE containing 0.5µg/ml 
ethidium bromide.The gel was run at a low voltage that helps to improve the resolution of the 
DNA fragments. DNA ladders were finally visualized by a UV light source and documented 
by photography. 
 
4.4 STATISTICAL STUDIES: 
 
 
 
All data are expressed as mean ± standard deviation. The datas were compared using students 
t – test and differences were considered significant, when p < 0.05. A p – value more than 
0.05 (p> 0.05) was taken as an indication of no significant difference. 
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                         CHAPTER 5: - 
 
 
 
 
 
RESULTS & DISCUSSION 
5.1 XRD ANALYSIS:-
Phase evaluation of hydrotalcite-like LDH material was performed using XRD. The pristine 
MgAl-LDH (3:1) precursor was prepared using co-precipitation of the component hydroxides 
at constant pH with carbonate and exchangeable nitrate anions in the gallery space. Here 
Figure 4 (a) shows the powder XRD patterns of pristine Mg-Al LDH.
FIGURE 4 (a): XRD pattern of synthesized Mg-Al LDH nanopowder 
The presence of both sharp and diffuse non-basal reflections in the XRD plot were taken as 
an indication of a partially disordered structure, resulted due to irregular stacking 
superposition of the regular unit layers. The pattern for MgAl - LDH was characteristic of the 
LDH structure with reasonabl y well crystallized hydrotalcite -like phase exhibiting rather 
sharp and symmetric 00l reflections. The basal spacing for (003), (d0 0 3 ) wa s estimated to be 
7. 94 Ȧ in pristine
MgAl - LDH . The powder XRD diffractogram of the LDH sample showed the structure of 
hydrotalcite displayin g the characteristic reflection . Firstl y with sharp and intense basal 00l 
reflections of 003 and 006 planes in the low angle region (2θ < 25°). Secondly broad 0kl 
reflections of 012, 015, and 018 planes in the middle angle region 
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(2θ = 30°-50°), and (iii) sharp hk0 and hkl reflections of 110, 113, and 116 planes, in the high 
angle region (2θ = 55°-65°). The short-range order in the brucite-like sheet of hydrotalcite 
were reported by Brindley and Kikkawa [1].The formation of a supercell with a 2:l Mg/Al 
ratio (corresponding to the maximum observed substitution of Mg by Al, thus x = 0.33) was 
also observed in some minerals by Taylor [2]. It was thus verified on the basis of geometric 
considerations. At higher Al content (x > 0.33), Al octahedra would become adjacent, thus 
leading to nucleation of Al(OH)3.With a Mg/Al ratio higher than 4 (x < 0.20), the location of 
the Mg ion favours the formation of brucite. In this case 3:1 Mg/Al (x=0.25) was taken as a 
precursor to synthesize Mg-Al layered double hydroxides.
FIGURE 4( b): Compar ative study of XRD pattern of Pristine LDH and Salicylate 
intercalated LDH nanopowder . 
Here figure 4(b) shows the comparative XRD pattern of pristine LDH and LDH-
SAnanohybrid synthesized using coprecipitation method, where SA remained intercalated 
into interlayers of LDH. The intercalation of salicylate into the MgAl-LDH matrix was 
evidenced by the shift of (003), (006) planes to higher d-values (Fig 1b). The gallery space 
for MgAl-LDH–salicylate hybrid material was found to be 8.90 Ȧ, which was higher than the 
longitudinal molecular length of 6.25 Ȧ for salicylate molecule. The basal spacing (d003) 
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increased from 7.94 Ȧ in MgAl-LDH to that 8.90 Ȧ in MgAl-LDH–salicylate hybrid because 
of intercalation of SA into the interlayer space of LDH. 
FIGURE 5: XRD Pattern of Pristine LDH and LDH -SA nanohybrid prepared using anion 
exchange method. 
Figure 5 shows the comparative XRD pattern of pristine LDH and LDH –SA nanohybrid 
prepared using anion exchange method . The d(003) value for LDH was increased from 7. 
94Å to 19.25Å in LDH -SA nanohybrid because of intercalation of long chain salicylate 
interlayer space and thereby expanding d(003) lattice phase. The carbonated LDH was tran 
sformed into nitrate containing Mg -Al LDH on exposure to the suspension, containing 0 
.0025 (M) HNO3 and 0.75 (M) NaNO 3 solution . The mild acidic condition decomposes the 
carbonate inside the LDH, keeping the LDH structure intact, and instead of 
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non -exchangabl e carbonate nitrate ions occupied the interlayer space of Mg - Al LDH . 
FIGURE 6 : Schematic representation of salicylate intercalation int o Mg Al LDH 
A schematic presentation of the intercalation of Salicylate into the LDH interlayers shown in 
Fig 6. Salicylate ion was intercalated into the gallery space of MgAl-LDH because of anion 
exchange between nitrate and salicylate in the reaction solution that was both due to gain in 
enthalpy and entropy. Nitrate being more hydrophilic and smaller in size would prefer to be 
solvated in aqueous solution at the expense of salicylate that is more hydrophobic and larger 
in size and thus going into the interlayer space of MgAl-LDH. Also entropic freedom of 
water molecule was much more enhanced in presence nitrate in the aqueous solution rather 
than salicylate. This explains why salicylate would rather prefer to go into the gallery space 
of LDH with nitrate being released into the aqueous solution. 
Figure 7 (a) shows the XRD pattern of Mg-Al LDH synthesized at pH 8.The XRD pattern 
obtained for as such synthesized Mg-Al LDH nanopowders showed not only characteristic 
peaks of the LDH material but also showed characteristic peaks of AlO(OH).The planes 
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(020), (040), (230) marked with (*) as in figure 7 (a) were found to be the characteristic 
planes of diaspore [AlO(OH)] when compared with a JCPDS ref code [79-1781]. It is clearly 
visible that apart from LDH, phases of γ AlO(OH) appeared in the XRD pattern of the as-
synthesized powder. The powder prepared at pH lower than 10 contained mixed phases of 
LDH and γAlO(OH), because of premature precipitation of aluminum hydroxide as compared 
to mixed aluminum hydroxide and magnesium hydroxide. On aging some fraction of 
aluminum hydroxide phases separated out from LDH phase to give rise to diaspore that has 
appeared in the XRD pattern of the synthesized Mg-Al LDH. 
.
FIGURE7 (a): XRD pattern of Mg-Al LDH nanopowder at pH 8. 
As such synthesized Mg - Al LDH powder on heat treatment at 500˚C for 2 hours formed 
metastable phases of Mg and Al oxides. Such heat treated powder on subsequent hydrol ysis 
in an aqueous solution of salicylate exhibited memory effect to reconstruct LDH -SA hybrids 
with SA intercalated into the interlayer space of LDH. Salicylate intercalation into the 
interlayer space of Mg Al LDH was confirmed from the shift of (003) plane of LDH to lower 
angle increasing the d003 to higher value in LDH-SA as compared to pristine LDH as in figure 
7(b). 
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FIGURE 7(b): Comparative study of XRD pattern of Pris tine LDH and 
 
Salicylate intercalated LDH nanopowder . 
 
 
 
 
 
But when compared with figure 4(a ),(b), it could be clearly observed that along with 
characteristic LDH peaks, some additional peaks of different material were present . After 
heat treatment, LDH forms some metastable phases that in the presence of water again 
hydrolyzed and reconstructed the LDH phase with intercalation of SA in the interlayer space. 
Since the starting powder contained some γ -Al -O -OH, on heat treatment, it helped in 
decomposition of LDH into component metastable oxides and hydroxides. That rehydrolyzed  
to form different hydroxides of Al and Mg along with retention of some LDH phase in the 
reconstructed material . Even after intercalation of s alicylate into LDH, the material 
contained mixed phases as seen in f i gure 7(b) . This can adversely affect the efficiency of 
LDH -SA nanohybrid as carrier and car go for controlled rel ease of the drug,  Thus  
generally  LDH  reconstruction  method  is  avoided  to  intercalate  SA into LDH for the 
purpose of controlled release of the anti -inflammatory drug . 
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5.2 PARTICLE-SIZE ANALYSIS:-
The hydrodynamic particle size of LDH and LDH-SA nanohybrids were determined using 
Dynamic Light Scattering (DLS) technique. It is known that if the size of particles 
responsible for photon scattering increases by one order of magnitude, the scattered light 
intensity increases by about a million times.The algorithm in the size measurement software 
converts the intensity of photon signal to size. 
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FIGURE 8(a): Particle size distribution of Pristine LDH 
FIGURE 8 (b): Particle size distribution of LDH-SA nanohybrid using coprecipitation 
method 
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The aqueous slurry of MgAl - LDH nanoparticles exhibited a particle size distribution 
between 30 -60 nm, with an average size of 45 nm with a pol ydispersit y index of 0. 576 
(PDI=0 .576) as in figure 8 (a) . The average hydrodynamic particle diameters of LDH -SA 
nanohybrids synthesized both by coprecipitation and anion exchange methods slightl y 
increased on salicylate intercalation . LDH -SA nanohybrids synthesized using anion 
exchange method showed narrower particle size distribution (PDI =0 .316) with an average 
particle size of 60 nm . Whereas, LDH - SA nanohybrid exhibited an average particle size of 
50 nm (PDI= 0. 365), which was synthesized using the coprecipitation method. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 8 (c): Particle size distribution of LDH-SA nanohybrid prepared using anion 
exchange method. 
 
 
 
 
The majority of the MgAl -LDH– salicylate nanohybrid nanoparticles have particle sizes 
below 100 nm, which suggests that most of these nanocarriers can  escape  the  
reticuloendothelial  system  (RES)  to  reach  the  target  cells during drug delivery. 
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5.3 TEM ANALYSIS:- 
 
 
Transmission Electron Microscopy (TEM) are capable of imaging at a significantly higher 
resolution than light microscopes, owing to the small de Broglie wavelength of 
 
electrons. This enables us to examine the fine details—even as small as a single column of 
 
atoms, which is thousands of times smaller than the smallest resolvable object in a light 
 
microscope. 
 
 
  
(b) 
 
(a)  
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FIGURE 9: TEM micrographs of (a) Pristine LDH (b) LDH - SA nanopowders prepared 
using co - precipitatio n (c) LDH - SA prepared using anion exchange 
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Figure 9 (a), 9 (b) and 9 (c) show the TEM micrographs of pristine LDH and LDH -SA 
nanohybrid prepared using coprecipitation and anion exchange methods respectively . The 
morphology of pristine LDH and LDH -SA nanohybrids by coprecipitation method 
represented the acicular and elongated shape . LDH pristine exhibited a size range between 
40 - 60 nm though the intercalated counterpart i . e. LDH -SA nanohybrid showed a little bit 
higher size range of 50 -80 nm . On the contrary, LDH -SA nanohybrids synthesized using 
anion exchange process exhibited distinctl y different spherical morphology with a size range 
between 45 -80 nm . The particle size of LDH - salicylate nano hybrid slightl y increased as 
compared to pristine LDH because of intercalation of the drug into the interlayer space . It 
was found that spherical nanocarriers exhibit better bio -distribution compared to its 
elongated counterparts during its transport through the blood to target cells. The movement of 
elongated nanoca rriers is little bit hindered through the blood stream and hence it requires 
greater time to reach the target cells to deliver drugs . As, anion exchange method exhibited 
better efficiency to intercalate SA molecules into the interlayer space of LDH and als o 
morphologicall y it is giving better equipped LDH -SA nanoh ybrids. Our subsequent studies 
and characterizations would be based on LDH -SA nanohybrids synthesized using anion 
exchange method . 
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ELEMENTAL COMPOSITIONAL ANALYSIS:- 
 
 
 
 
Elements Atomic Percent (%) 
   
 MgAl LDH MgAl LDH -SA (AE) 
   
Mg 24.92 19.85 
   
Al 8.25 6.75 
   
O 60.37 47.72 
   
N 5.67 1.26 
   
C 0.78 24.75 
   
 
 
TABLE I: EDS analysis of LDH and LDH-SA nanopowders synthesized using 
anion exchange process 
 
 
From the EDS anal ysis (Table I) of pristine LDH and LDH – SA nano -hybrid, it is clear that 
Mg:Al ratio (3.02:1) in the synthesized powder closel y resembled with the theoretical 
composition (Mg: Al= 3:1) . The presence of increased amount of carbon in the LDH - SA 
nanohybrid powder signified the intercalation of sal icylate into the interlayer space of LDH . 
This result obtained here clearly supports the data as obtained from DSC - TG of the samples 
bare LDH, sole SA drug and the Mg Al - SA LDH nanohybrid . 
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5.4 FTIR ANALYSIS:- 
 
 
FTIR analysis is not a diagnostic tool for hydrotalcite, but can prove to be useful to identify 
the presence of foreign anions intercalated in the interlayer of the brucite-like sheets. Besides 
that, information about the type of bonds formed by the anions and their orientations can also 
be detected by this spectroscopy. The FTIR spectra of pristine LDH, SA molecule, and LDH– 
SA hybrids are shown in the following Figure 10. 
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FIGURE 10: FTIR Spectroscopy of Pristine LDH, LDH-SA, Salicylic Acid powder 
 
 
Two bands at 600 and 428 cm
-1
 attributed to the lattice vibrations of metal–oxygen and 
metal–hydroxyl bonds. The presence of bands in 200-1000 cm-1region are attributed to the 
vibrations of the anions, and whereas some are related to cation-oxygen vibration. The 
absorption band at 3480 cm
-1
 signifies the stretching vibration of the labile hydroxyl group or 
physically adsorbed water molecule in the brucite-like layer of Mg-Al-LDH [4]. Serna et al. 
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[5] showed that both the hydrogen stretching and bending frequencies in the hydrotalcite 
increase as the M(II)/M(IlI) ratio increases from 2 to 3. This shift correlated with the 
modification in the layer spacing; moreover, it was observed that the half-width was smaller 
in the Mg/Al= 2/l (x= 0.33) hydrotalcite, thus suggesting a more ordered cation distribution 
inside the brucite-like layer. A shoulder was present around 3000 cm
-1
; which attributed to 
hydrogen bonding between H20 and the anion in the interlayer water, bending vibration also 
occurs at 1600 cm-
1
. The intensity of these latter two bands depends on the type of anion and 
the amount of water in the LDH. The presence of a strong band at 1384 cm
-1
 signifies the 
existence of NO3
-
 anions in MgAl-LDH structure [6]. 
 
In most cases of hydrotalcite-like material the bands observed at 1350-1380 cm
-1
 (v3), 850-
880 cm
-1
(v2) and 670-690 cm
-1
 (v4), as well as in some cases the presence of a shoulder 
around 1400 cm
-1
, or of a double band in the region1350-1400 cm
-1
[7], attributed to 
lowering of the symmetry of the carbonate (site of symmetry C2v). It also attributed to the 
disordered nature of the interlayer [7,5], which subsequently caused the removal of the 
degeneracy of the v3 and v4 modes. The lowering of the symmetry also causes the activation 
of the v1 mode at around 1050 cm
-1
. Miyata [8] explained the observed lowering of symmetry 
by hypothesizing two different kinds of carbonate anion coordination; existing in the 
interlayer region as a monodentate or a bidentate complex. The author had also reported the 
same explanation to justify the band splitting in some hydrotalcite containing different anions 
[(NO3)
-
, (SO4)
2-
, (ClO4) [8,9] 
 
Serna et al. [10] explaining differently, hypothesized that the bands observed at 1625 cm
-1
 
could be related to the presence of bicarbonate ions, whereas the splitting of the band around 
1380cm 
-1
, as well as the appearance of the band at 1060 cm
-1
 , related to a perturbation of 
the carbonate anion under vacuum. 
 
The presence of several functional groups in the salicylic acid gave rise to a spectrum with 
many absorption bands. The band attributable to C=O vibration of the acid has vanished 
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because the salicylic acid was intercalated in the anionic form inside the LDH. Intense bands 
have been found to develop at 1566 cm
-1
, 1453 cm
-1
, and 1348 cm
-1
 that attributed to the
asymmetric and symmetric carboxylate stretching mode of the salicylate anions.[11,12].In 
addition to bands at high wave number values due to  (OH) and  (=C–H) moieties, a band 
was recorded at 1658 cm
-1
 due to mode  (C=O) of the acid group. The abnormally low value
for the position of this band was due to intramolecular hydrogen bonds. The bands due to  
(C–C) of the aromatic ring were assigned to 1605, 1484, and 1467cm-1. While those due to
modes  (C–O) and  (O–H) of the acid and alcohol functions were recorded at 1441 and 
1290 cm
-1
  respectively. The In-plane and out-of-plane  (CH) bands were recorded below
1000 cm
-1
[13]. Peaks at1573 and 1376 cm
-1
   attributed to the as and s vibration of COO-.
After the ion-exchange reaction, the as and s  absorption peaks of –COO –  moved to 1608
and 1432 cm
-1
 respectively. These results indicated the presence of strong electrostatic
interactions between the cationic host layers and the salicylate anions [12,14]. 
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5.5 THERMAL ANALYSIS:- 
 
 
LDHs are reactive materials that undergo endothermic decomposition producing water and 
metal oxide residue. This property could be useful in improving the thermal stability and 
flame-retardance of polymer matrix more efficiently. The thermal behaviour of the 
hydrotalcite material generally characterized by two transitions: firstly , endothermic at low 
temperature which corresponds to the loss of interlayer water, without the collapse of the 
structure; this step is reversible [15]. And secondly, endothermic, at a higher temperature that 
is due to the loss of hydroxyl groups from the brucite-like layer, as well as of the anions. 
These two transitions depend quantitatively and qualitatively on many factors, such 
as:M(II)/M(III) ratio, the type of anions, low temperature treatment (hydration, drying, 
etc),and the heat treatment atmosphere. 
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FIGURE 11 (a): Thermogravimetric plot of LDH, SA, LDH-SA nanopowders 
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Thermogravimetric curves (TG), carried out on LDH, SA, and LDH–SA under air purge 
(thermo-oxidative analysis), are shown in Figure 11(a). The Mg Al-LDH powder showed a 
typical thermogram of hydrated product losing 46.17% of its mass on heating till 1000 
o
C. 
On the other hand, the salicylate intercalated LDH powders exhibited a mass loss of about 
68.69%. Considering, the fact that SA fully decomposed within this temperature range, the 
amount of SA intercalated into Mg Al LDH was found to be 22.5%. The mass loss in Mg-Al 
LDH was spread over three major regions as evident from the TG-DTA plot in Figure 11 
(a,b). 
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The first endothermic peak at 130 ˚C was due to the removal of adsorbed moisture. This 
followed by the double endothermic effects at 370 and 395 ˚C, which contribute to the loss of 
interlayer water and charge balancing interlayer nitrate ions respectively. 
The lower mass loss at higher endothermic temperatures (510 ˚C) attributed to the 
dehydroxylation and decarboxylation process leading to the conversion of the LDH into 
MgAl2O4spinel. The interesting shift in decomposition temperature of salicylate due to 
endothermic shift from 320 
o
C to 350C attributed to the higher thermal stability of salicylate
in the interlayer space of LDH as compared to its free state. 
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5.6 FESEM ANALYSIS:-
Field emission scanning electron microscopy (FESEM) provides a topographical and 
elemental information at magnifications of 10x to 300,000x, with virtually unlimited depth of 
field. When compared with conventional scanning electron microscopy (SEM), field 
emission SEM (FESEM) produces clearer, less electrostatically distorted images with spatial 
resolution three to six times better. 
(a) (b)
FIGURE 12: FESEM analysis of (a) Mg-Al LDH nanopowder (b) Mg-Al LDH-SA 
nanohybrid. 
The average particle size of the Mg-Al LDH nanopowder as observed from figure 12 (a) was 
found to be around 20-40 nm. Whereas on the other hand the average particle size of the Mg-
Al LDH-SA nanohybrid nanopowder was estimated to be around 30-80 nm as in figure 12 
(b). Since the increase in the average particle size of the intercalated nanopowder is clearly 
evident from the figure 12 (b). So it strongly supports the fact that salicylate intercalation into 
the interlayer space of the Mg-Al LDH nanopowder caused expansion of crystal lattice. 
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FIGURE 13: FESEM analysis of (a) Heat – treated Mg-Al LDH nanopowder (b) Mg-Al 
LDH-SA reconstructed nanohybrid. 
 
 
 
Since from figure 13 it can be clearly said that the average particle size of , both the pristine 
Mg-Al LDH nanopowder and the salicylate intercalated LDH nanohybrid increases on being 
heat treated. So heat treated material in case of controlled release of Layered Double 
 
Hydroxide won’t be a very suitable idea. 
 
 
The calcined Mg-Al LDH powder showed nanoplatelet like morphology. The 500°C calcined 
Mg-Al LDH powder on reconstruction in the presence of an aqueous solution of Salicylate, 
formed Salicylate intercalated Mg-Al LDH. Though LDH-SA powder on drying formed 
agglomerated platelets and bands of assembled platelets is clearly visible in SEM 
micrographs in figure 13 (b). The average particle size Of LDH and SA-LDH nanohybrid 
increased due to crystal growth and agglomeration due to calcinations at 500°C. So, it can no 
longer escape the Reticulo Endothelial System (RES) to avoid phagocytosis. Thus, the 
powders are suitable for carrying the drug through the blood to specific sites of the body. 
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5.7 CHN ANALYSIS:- 
 
 
A CHN Analyzer is a scientific instrument that determine the elemental composition of a 
sample. The name derives from the three primary elements measured by the device: carbon 
(C), hydrogen (H) and nitrogen (N). Sulfur (S) and oxygen (O) can be also measured. Such 
analyzers usually use very small quantities, many times around 1 to 3 mg of the sample.The 
analyzer uses a combustion process to break down substances into simple compounds that are 
then quantified, usually by infrared spectroscopy. 
 
 
Element Content (%)  
   
 LDH LDH-SA (AE) 
   
C 0.39 16.06 
   
N 5.21 2.16 
   
H 2.28 3.59 
   
 
 
TABLE II: CHN analysis of LDH and LDH-SA nanopowders 
 
 
 
The CHN analysis of MgAl-LDH and MgAl-LDH–SA are given in Table II. The amount of 
SA intercalated into the interlayer space of MgAl-LDH was found to be 263.84 mg of SA/g 
of LDH–SA. This corresponds to approximately 26.4wt% SA in the LDH–SA formulation, 
which is in close agreement with data obtained from the thermogravimetric analysis. 
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5.8 IN-VITRO DRUG RELEASE:- 
 
 
 
The salicylate release profile from the LDH matrix at physiological pH (7.4) at a 
constant temperature of 37.1˚Ċ was evaluated in the phosphate buffer solution using a 
UV-visible spectrophotometer. 
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FIGURE15: Fit of first order release kinetic data to observed release rate 
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The release of the drug up to 20 hours followed a faster kinetics though no burst release was 
observed at the beginning of the release tests. This phenomenon primarily attributed to the 
release of loosely bound SA molecules from the edges of interlayer spaces and free surfaces 
followed by subsequent release of salicylate anion from the interlayer space of LDH due to 
de-intercalation. The later stage of slower release (after 20 hours) of salicylate governed by a 
combination of drug diffusion and LDH dissolution. The release profile shows that ~50% of 
the incorporated salicylate was released in 16 hours, and it increased nonlinearly to ~80 % in 
30 hours. The entire amount (~99%) of salicylate was released within the time frame of 72 
hours that clearly showed the ability of LDH in controlled and sustained drug release. The 
cumulative release (%) of salicylate was nonlinear with respect to elapsed time and exhibited 
an exponential release rate as given in Figure 14. 
X= Mt /M∞= X0-Aexp (-t/) ………………..(1) 
Where X0= 0.9753, A= -0.8946 and = 14.023 in this case. 
…………………….(2) 
………………………………………(3) 
X= k t
n
 …………………………(4)
X= …………………………(5) 
where X, t, k,  and n are the fraction of drug release, release time, kinetics constant, 
modified parameter and an exponent respectively. 
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FIGURE 16: Release kinetic filled to zero order reaction kinetic 
FIGURE 17: Release kinetic fitted to Higuchi model 
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FIGURE 18: Release kinetic fitted to Rigtus- Peppas model 
FIGURE 19: Release kinetic fitted to Korsmeyer- Peppas model 
The SA release data was fitted to zero-order[19] [Figure 14], first-order [Eq.(2)] [20],Higuchi 
(Eq.(3)[20,21] [Figure 17], Rigter–Peppas (R–P) model [Eq.(5)] [20] [Figure 18], and 
Krosmeyer- Peppas [Eq (4)] [22] [Figure 19] to investigate the release dynamics of this 
system. 
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Sample Zero First Higuchi R
2
Korsmeyer- Peppas Rigter- Peppas Model 
Order R
2
 Order Model 
R
2
R2 n R2 n 
LDH- 0.8346 0.9816 0.8455 0.97 0.4611 0.9729 0.4533 
SA 
TABLE III: Drug release kinetic parameters derived from UV- visible spectrophotometer 
Release exponent Drug Transport Mechanism Rate as a function of time 
0.5 Fickian Diffusion t -0.5
0.45 < n = 0.89 Non Fickian transport t n-1
0.89 Relaxational Transport Zero Order Kinetics 
>0.89 LDH dissolution t n-1
TABLE IV: Interpretation of diffusional release mechanisms from LDH- SA nano hybrid. 
The derived fitting parameters of , n and R are given in Table III. The exponent n is 
normally used to describe different release mechanisms as shown in Table IV. The fitting 
results of drug release profiles on the basis of the first order release kinetics model are shown 
in the figure15. It is evident that the SA drug release from LDH followed first order release 
kinetics with a satisfactory coefficient of 0.9816. This was also followed by Rigter –Peppas 
(R-P) model of release kinetics (Table III) with a fitting coefficient of 0.9729. The value of n 
is 0.4533 (0.45<n<0.89) in R–P model at pH 7.4 indicates that SA drug release mechanism 
from Mg-Al LDH controlled by the non- Fickian transport mechanism. Which is a 
combination of diffusion and LDH dissolution in physiological solution [19,20], that is 
closely relevant to first order release kinetics. 
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5.9 DISSOLUTION STUDY USING ATOMIC ABSORPTION 
SPECTROSCOPY:
Atomic absorption spectroscopy (AAS) is a spectro-analytical procedure for the quantitative 
determination of chemical elements using the absorption of optical radiation (light) by free 
atoms in the gaseous state. This technique makes use of absorption spectrometry to assess the 
concentration of an analyte in a sample. It requires standards with known analyte content to 
establish the relation between the measured absorbance and the analyte concentration and 
relies therefore on the Beer-Lambert Law. 
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FIGURE 20: Dissolution kinetic of Mg-Al LDH in PBS of pH 7.4 
The kinetic dissolution data for Mg-Al LDH in figure 20 shows that significant degree of 
dissolution was observed in LDH immersed in PBS solution of pH 7.4 within 4 hours of 
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immersion time. After 30 hours, the rate of dissolution of MgAl LDH at pH 7.4 became 
significantly higher and increased continuously after that up to 60 hours. At initial stages, the 
dissolution of surface layers of LDH may not influence the drug release kinetics. After 30 
hours, the rate of LDH dissolution was high enough to cause disintegration of intercalated 
structure of LDH to release drug molecules. Atomic absorption spectroscopy data in figure 
20 clearly suggests that dissolution of MgAl LDH into PBS of pH 7.4 played a vital role in 
determining its salicylate release behaviour particularly at the later stages, after 30 hours of 
incubation in PBS. 
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5.10 HEMOCOMPATIBILITY ANALYSIS:-
Hemocompatible materials are those substances that cause no negative influence on blood. 
Blood represents one of the most complex biochemical systems in living organisms. Its 
various components play integral roles in several life functions, including the transport of 
oxygen, destruction of invading pathogens, and repair of damaged tissue. Medical devices 
that contact blood during routine use must be hemocompatible. That is, they must not 
adversely interact with any blood components so as to cause their inappropriate activation or 
even destruction. Blood is composed of a multitude of cell types, ranging from simple 
oxygen-carrying erythrocytes to sophisticated antigen-specific lymphocytes. The various 
cells participate in a vast array of functions, including tissue repair and immune responses as 
well as oxygen transport. Because of the range and criticality of these functions, any source 
of cytotoxicity to blood cells can cause significant harm. Most significantly for example 
hemolysis, the breakdown of red blood cells, which can be material-mediated or result from 
mechanical damage and directly impairs the ability of the circulatory system to carry oxygen 
to body tissues. Likewise, adverse interaction with white blood cells can impair the body's 
ability to eliminate invading pathogens efficiently. Blood also contains several soluble 
multicomponent protein systems that systematically interact in various ways to perform 
critical functions, like the complement system participates in inflammatory reactions and 
facilitates removal of invading pathogens. Similarly, the clotting cascade operates to initiate 
coagulation, thereby preventing excessive loss of fluid and facilitating tissue repair. 
Inhibition of either of these cascade systems can have significant adverse effects on the body. 
Therefore, a structured test -selection system is performed primarily based on clinical 
concerns. 
The hemocompatibility tests were performed for the layered double hydroxide samples as per 
the American Society for Testing and Materials (ASTM) standard protocol, which figures out 
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the extent of hemolysis in the presence of samples. Here for the tests to perform fresh goat 
blood was collected in the presence of Tri Sodium Citrate (TSC) in the proportion of 3.8 gm 
of TSC per 100 ml of blood to prevent the coagulation of blood vessels. The citrated blood 
thus obtained was then diluted with normal saline in the ratio of 8:10 (blood: saline). Then 
0.5 ml of diluted blood is taken in a centrifuge tube 
FIGURE 21 : Samples prepared for the hemolysis test. 
Results obtained:- 
TABLE V: The OD values obtained after the hemocompatibility test for LDH, SA, LDH-
SA nanohybrid 
+ve (control) -ve (control) LDH LDH-SA SA 
(AE) 
OD values 0.324 0.104 0.115 0.113 0.116 
TABLE VI: Percentage Hemolysis for the three samples against the OD values. 
LDH LDH-SA (AE) SA 
% Hemolysis 5.0 4.2 5.5 
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FIGURE 22: Percentage hemolysis of free SA, LDH, and LDH –SA nanohybrid. 
From figure 22, it is visibly clear that all the samples were hemocompatible. The ceramic 
nano- powder LDH (pristine) having a hemolysis percentage value of 5, indicated that the 
sample is hemocompatible with blood cells of the body. The sole drug-free salicylic acid with 
a percentage hemocompatibility of 5.5 attributed to the fact that it is not highly 
hemocompatible but is mildly compatible with the blood cells of the body. The intercalated 
sample Mg-Al LDH-SA nanohybrid showed percentage hemolysis of 4.2. Thus, it clearly 
indicates high hemocompatibility of LDH-SA with the blood cells. That means, SA in 
intercalated of LDH is more hemocompatible than the free salicylic acid. 
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LDH-SA 
5.11 MTT ASSAY ANALYSIS:-
The term MTT assay refers to a colorimetric assay used for assessing cell metabolic activity. 
The cytotoxicity of the synthesized material was determined using the MTT assay. These are 
cell viability, and cytotoxicity assays used for drug screening and cytotoxicity tests of 
chemicals. Various reagents are being used for cell viability detection, 
based on various cell functions such as enzyme activity, cell membrane permeability, cell 
adherence, ATP production, co-enzyme production, and nucleotide uptake activity. MTT 
assay measures the reduction of yellow 3-(4, 5-dimethythiazol- 2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT) by the enzyme mitochondrial succinate dehydrogenase. 
The cell line used for measuring MTT assay of Mg-Al LDH were HEK 293, popular for their 
ease of growth and transfection. HEK293 is a cell line derived from human embryonic kidney 
cells grown in tissue culture. They are also known, more informally, as HEK cells.The MTT 
enters the cells and passes into the mitochondria where it reduces to an insoluble, colored 
(dark purple) formazan product. The insoluble purple colored formazan are then solubilized 
with an organic solvent (e.g.,. isopropanol) and the color intensity released, solubilized 
formazan reagent is measured spectrophotometrically . Since the reduction of MTT can only 
occur in metabolically active cells the level of activity is a measure of the viability of the 
cells. Below is the reaction of MTT being converted to Formazan on treatment with 
mitochondrial reductase. 
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FIGURE 23: Reaction showing conversion of MTT to Formazan 
The graph plotted against the data’s obtained shown below:- 
FIGURE 24 : Cytotoxicity analyzes of Mg-Al LDH, SA & LDH –SA at 25 – 1.562 μg/ml 
on HEK 293 cells using the MTT assay. 
[where * p < 0.05, θ p < 0.03, ρ p < 0.02, σ p < 0.03, φ p < 0.042 ,compared 
with the corresponding control group (Mg Al LDH) ] 
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MTT assay was thus performed using HEK 293 cell lines cultured in the MEM & FBS media. 
It was found all materials, were mildly toxic towards the cells. Pure ceramic nanoparticle Mg-
Al LDH was found to be least toxic as when compared with the free Salicylic Acid sample 
and the Mg-AL LDH-SA nanohybrid. From the plot, it is clearly visible that cell viability (%) 
of salicylic acid increased with decreasing concentration of the sample being introduced into 
the cells. SA intercalated LDH (LDH-SA) followed the same trend. 
Cell viability in contact with free SA increased from 70 % at 25 μg/ml to 95% at a lower 
concentration of 1.562 μg/ml. Similarly the cell viability of the LDH-SA sample (i.e. the 
nanomaterial intercalated with the drug salicylic acid) increased from 85% at 25 μg/ml to 
almost 99% at 1.562 μg/ml. It clearly attributed that higher concentration (25 μg/ml) of LDH-
SA imparts a condition that is more cytotoxic that indicated a cell viability of 85% .Whereas 
when the concentration of the sample decreased to 1.562 μg/ml, the cell viability increased to 
99 %, making it more conducive to cell growth and proliferation. Since the number of viable 
cells were more in the presence of the same amount of SA intercalated LDH sample as 
compared to the free SA, the drug intercalated inside LDH exhibited lower cytotoxicity. 
Inspite of the samples being non-toxic no conclusive effect of concentration on cell viability 
could be drawn from these test results. Exposure to a higher concentration of the test samples 
for prolonged duration were probably required for the determination of an IC 50 value for 
each of the test samples. This would be required to obtain more comprehensive information 
on the effect of test materials on cell viability of the samples. On the basis of which the effect 
of the nanohybrid material could be carried out at the molecular level. Thus, it can be said 
that SA in an intercalated form inside the LDH nanomaterial is less cytotoxic to human 
kidney cells in comparison to the bare drug itself. 
66 
5.12 DNA FRAGMENTATION ANALYSIS:-
DNA fragmentation is the separation or breaking of DNA strands into pieces. It can be done 
intentionally by laboratory personnel or by cells, or can occur spontaneously. Spontaneous or 
accidental DNA fragmentation is molecular fragmentation that gradually accumulates in a 
cell. It can be measured by e.g. the Comet assay. Here the analysis of DNA fragmentation 
was performed using agarose gel electrophoresis method after culturing HEK 293 [Human 
Embryonic Kidney cells] cell lines in the presence of samples. The cells were first of all 
retrieved in a mixed solution of MEM [Minimum essential media (45 ml)] along with 10 % 
FBS [Foetal Bovine Serum (5ml)] media. The stored cells are thus mixed with the media and 
attached to the surface of the flask in which the cells were seeded when they were grown. The 
cells were thus kept in the media for 24 hrs to study their nature of growth. 
FIGURE 25: Effect of MEM + FBS media on the HEK 293 cells 
The microscopic images of HEK 293 cells in figure 25 shows the effect of sole DMEM media 
on the HEK 293 cells after 24 hours of culture. The cells are looking very healthy with micro 
extentions on the substrate.The three samples Mg-Al LDH nanoparticle, bare salicylic acid, 
and the Mg-Al LDH-SA nanohybrids were taken for the treatment of these cells to study 
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the DNA fragmentation analysis. 0.1mg /mL of each of these samples were taken for the 
study. 
FIGURE 26: Effect of (a) Media (control) (b) LDH (c) SA (d) LDH-SA on the HEK 293 
cells after 24 hrs of treatment 
The microscopic images as seen above describe the effect of three samples on the HEK 293 
cells after 24 hrs of treatment. As seen from figure 26 (a) the number of viable cells was more 
in control in presence of only growth media, whereas the number of viable cells were less 
when the cells were being treated with LDH nanopowders as is seen in figure 26 (b). The 
number of viable cells abnormally decreased when treated with the bare salicylate drug as 
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seen in figure 26 (c) , thus revealing its cytotoxic nature.When intercalated into the interlayer 
space of the LDH nanopowders, the cytotoxicity of the SA was decreased as seen from figure 
25 (d). 
FIGURE 27: Effect of (a) Media (control) (b) LDH (c) SA (d) LDH-SA on the HEK 
293 cells after 48hrs of treatment 
The microscopic images as seen above in figure 27 describe the effect of three samples on 
HEK 293 cells after 48 hrs of treatment. As seen from figure 27 (a) the number of viable cells 
was more in control in presence of only growth media, whereas the number of viable cells 
was less when the cells were treated with LDH nanopowders as seen in figure 27 (b). The 
number of viable cells was least when the cell line was treated with bare salicylate drug as 
seen in figure 27 (c).In comparison, the cell line when treated with the LDH-SA nanohybrid 
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appeared to be more healthy and higher in number as compared to the bare LDH and the bare 
SA treated cell lines. 
FIGURE 28 : Agarose gel electrophoresis of DNA fragmentation on HEk 293 cells 
(a) Lane 1: Control (b) Lane 2: LDH (c) Lane 3: SA (d) Lane 4: LDH-SA. 
DNA fragmentation is a key feature to measure cell death. Figure 28 clearly shows the 
nature of cell growth and their subsequent death due to the treatment of the cells with the 
test samples after 48 hrs. Excessive cell death was observed in the cell plate treated with 
that of free Salicylate. The higher amount of cell death, when treated with SA, was also 
attributed to the higher smear and clear ladder formation observed in the agarose gel 
electrophoresis as shown in figure 28. When the cells are treated with the intercalated 
nanohybrid LDH-SA there was very little or in fact negligible amount of cell death, or 
negligible ladder formation similar to that as observed in the log phase i.e. the control cell 
plate with no smear being observed in the agarose gel electrophoresis.This proves the 
higher biocompatibility of the LDH-SA nanohybrid in comparison to the free salicylate. 
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CHAPTER 6: -
CONCLUSION & SCOPE OF
FUTURE WORK
6.1 CONCLUSION: 
In the present study, Mg Al LDH-salicylate inorganic –organic nanohydrid was synthesized, 
and its effectiveness in the controlled and sustained release of salicylate was evaluated in 
vitro. It has also been shown that SA in the intercalated form inside the interlayer space of 
Mg-Al LDH was less cytotoxic to human embryonic kidney cell line as compared to the sole 
salicylate drug taken orally or intravenously. The results of the aforementioned work can be 
summarized as follows. 
(i) LDH was synthesized in the particle size range of 40 -70 nm. 
(ii) Successful intercalation of Salicylate in the interlayer space of Mg-Al-LDH was 
confirmed by XRD data and FTIR Spectroscopy of the intercalated nanohybrid. 
Salicylate is loaded to the extent of 24 wt% in the LDH salicylate formulation. 
(iii) It was evident that the SA drug release from LDH followed first order release 
kinetics with a satisfactory coefficient of 0.9816. The drug release rate followed 
an exponential dependence with respect to incubation time with a combination of 
drug diffusion and LDH dissolution mechanism. 
(iv) Cytotoxicity of the samples were determined using MTT Assay and the Hemolysis 
tests that showed that SA intercalated into the interlayer of LDH was less 
cytotoxic as compared to bare SA drug. 
(v) Further DNA fragmentation by the gel electrophoresis method showed that LDH-SA 
treated cells underwent less cell death as compared to the bare SA treated kidney 
cells, which supports higher biocompatibility of LDH-SA nanohybrid to kidney 
cell than the bare SA drug. 
(vi) The advantage of using SA intercalated LDH nanocarrier instead of bare NSAID on 
minimizing damage to human kidney cells is evidently supported by all the 
cytotoxicity tests. 
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(vii) This work supports that Mg AL-LDH nanopowder can be a very effective carrier for 
controlled and sustained release of NSAIDs under physiological conditions. 
6.2 SCOPE OF FUTURE WORK: 
In recent years, inorganic materials have inspired considerable interest in the fields of 
chemical, biological, and drug delivery applications. A new type of layered inorganic 
material, layered double hydroxides (LDHs), has especially generated a lot of interest for 
research. For example, LDHs showed potential applications for CO2 capture materials, 
biomolecular reservoirs, catalysts, contrast agents,and for agricultural applications. For 
pharmaceutical applications, LDHs have given rise to great interest because the nanocarriers 
can control the release of active drugs and biological molecules for the design of targeting 
delivery systems. 
The feasibility of LDH nanoparticles to develop organ specific targeting by incorporation of 
an NIR fluorescent dye, indocyanine green(ICG), in the layered structures of amine-modified 
LDHs can be studied. The produced LDHs–NH2–ICG complexes were further coated with different 
amounts of chitosan molecules by a covalent cross-link of amino groups between the LDHs–NH2 and 
chitosan molecules through glutaraldehyde as a cross-linking agent. The combination of LDHs and 
ICG can apply to invivo optical imaging because the excitation and emission at long wavelengths(ex: 
780 nm; em: 820 nm) in the NIR window where blood and tissue are relatively transparent. We can 
easily control the bio-distribution of LDHs by using different amounts of a biodegradable polymer 
such as chitosan coated on the external surfaces of LDHs–NH2–ICG. It can be exhibited that the 
chitosan-coated LDHs–NH2–ICG complexes possess high biocompatibility, high fluorescence 
intensity, highly organ-specific targeting and low cytotoxicity. The chitosan-coated LDH surfaces can 
increase the stability of the nanocomposites; furthermore, the targeting molecules can be conjugated 
in the external surfaces of the chitosan molecules through a further reaction with the amino groups. 
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